PreciseDx

PreciseDx is an artificial intelligence company operating in the New York City healthcare sector [1]. Founded in 2020, the company focuses on oncology diagnostics [2]. PreciseDx leverages artificial intelligence for morphology-driven disease analysis, utilizing a proprietary technology called Morphology Feature Array (MFA) [2]. According to company information, the platform provides disease insights and actionable intelligence to support decision-making across the cancer care continuum [2]. The company operates in the medical and diagnostic laboratories industry [3] and employs 28 people [3].

Something wrong or missing? Send a correction. Fixed within 24 hours.